The first biologic treatment
of its kind for active PsA
TREMFYA® is a biologic treatment, and the first medication of its kind to be approved by the Food and Drug Administration (FDA) for adults with active psoriatic arthritis.
TREMFYA® has 15+ years of combined clinical research* and 7+ years on the market across indications.
*Based on a clinical trial of TREMFYA® initiated in 2009.
Results with TREMFYA®:
less joint pain, stiffness, and swelling
Results with TREMFYA®:
less joint pain, stiffness,
and swelling
At 24 weeks
At 24 weeks
In two medical studies, more than 5 out of 10 people who took TREMFYA® had at least a 20% improvement in active PsA symptoms (joint pain, stiffness, swelling) at 24 weeks compared to placebo. Individual results may vary.
At 2 years
At 2 years
One medical study showed that less joint pain, stiffness, and swelling is possible even at 2 years.†
†For patients who continued on TREMFYA® for 2 years, a similar percentage (7 out of 10 patients) saw a 20% improvement in PsA symptoms at 2 years. At 24 weeks and thereafter, patients and healthcare providers knew that TREMFYA® was being used. This may have increased results. Individual results may vary.
†For patients who continued on TREMFYA® for 2 years, a similar percentage (7 out of 10 patients) saw a 20% improvement in PsA symptoms at 2 years. At 24 weeks and thereafter, patients and healthcare providers knew that TREMFYA® was being used. This may have increased results. Individual results may vary.
TREMFYA® Safety Information
Ask your doctor about the benefits and risks of TREMFYA®. Prescription medications, including TREMFYA®,
have possible risks involved with treatment, so it’s important to discuss them with your doctor.
TREMFYA® may cause serious side effects, including:
Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
These are not all the possible side effects of TREMFYA®.
Please read the Important Safety Information located at the bottom of the screen and the Medication Guide for TREMFYA® to learn more about these and other risks for TREMFYA®. Discuss any questions you have with your doctor.
TREMFYA® may cause serious side effects including:
These are not all the possible side effects of TREMFYA®. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How often will you need
to take TREMFYA® ?
Day 1
1 injection on day 1
Week 4
1 injection 4 weeks later
Week 12 & beyond
1 injection every 8 weeks
You can take TREMFYA® by using the prefilled syringe, One-Press injector, or prefilled pen.
TREMFYA® is a single-dose 100 mg injection taken under the skin at weeks 0 and 4, and then every 8 weeks. That’s only 6 doses per year after 2 starter doses.

Not Actual Size
You can take TREMFYA® by using the prefilled syringe, One-Press injector, or prefilled pen.
TREMFYA® is a single-dose 100 mg injection taken under the skin at weeks 0 and 4, and then every 8 weeks. That’s only 6 doses per year after 2 starter doses.
If your healthcare provider decides that you or a caregiver may be able to give your injections of TREMFYA® at home, you should receive training on the right way to prepare and inject TREMFYA®. Do not try to inject yourself until you have been trained by your healthcare provider.
For children, TREMFYA® should be administered by a healthcare provider or an adult caregiver who has been shown the right way to give the injections by a healthcare provider.
Please read the Instructions for Use before using TREMFYA®, and each time you get a refill. There may be new information. These instructions do not take the place of talking with your healthcare provider about your medical condition or your treatment.
Want to know more about dosing with TREMFYA®? Click here.